March 14th, 2011
AHA Offers Qualified Endorsement of Weight-Loss Surgery
Larry Husten, PHD
For the first time, the AHA has offered a qualified endorsement of bariatric surgery. The scientific statement, published in Circulation, states that bariatric surgery is a relatively safe procedure that can lead to long-term weight loss and significantly improve health in appropriately selected obese patients who have been unable to lose weight nonsurgically.
But, said Paul Poirier, the lead author of the statement, in an AHA press release, “it is not an across-the-board endorsement of bariatric surgery for the severely obese. It is a consensus document that provides expert perspective based on the results of recent scientific studies.”
The statement notes that surgical weight loss can “completely reverse established diabetes mellitus in a large percentage of subjects” and results in improvements in lipids, inflammation, nonalcoholic fatty liver disease, hypertension, sleep apnea, and cardiac function. The report states that “there is increasing, although not definitive, evidence that bariatric surgery provides a significant survival benefit.”
Categories: General, Prevention
Tags: bariatric surgery, obesity, weight loss
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
One Response to “AHA Offers Qualified Endorsement of Weight-Loss Surgery”
-
NEJM Journal Watch — Recent Cardiology Articles
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?
-
Sign up for NEJM Journal Watch Cardiology Alerts
Receive a free weekly email with the latest summaries on Cardiology.
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
There is no doubt that bariatric surgery is useful in morbidly obese, but the judicious selection of patients ,taking into account their personality profile is of the utmost importance.The so called “complete reversal of diabetes” is yet to be observed on a long term basis.
Competing interests pertaining specifically to this post, comment, or both:
none